The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model.
about
The 9L(LUC)/Wistar rat glioma model is not suitable for immunotherapy.Targeting the tumor microenvironment to enhance antitumor immune responsesRat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70.Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
P2860
The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model.
@en
The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model.
@nl
type
label
The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model.
@en
The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model.
@nl
prefLabel
The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model.
@en
The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model.
@nl
P2093
P2860
P356
P1476
The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model.
@en
P2093
Ayhan Bilir
Cengiz Kuday
Galip Z Sanus
Mustafa O Ulu
Necmettin Tanriover
Resit Canbeyli
P2860
P304
P356
10.1179/174313208X289516
P577
2008-06-01T00:00:00Z